Japan Tobacco Inc. announced resolutions from the Board of Directors concerning the Company's new executive appointment. Newly appointed Executive Officer (Effective from July 1, 2024): Takayuki Yamaguchi as Senior Vice President, President, Pharmaceutical Business. Resigning Executive Officer (As of June 30, 2024): Muneaki Fujimoto as Senior Vice President, President, Pharmaceutical Business.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,432 JPY | +0.43% | -0.72% | +21.37% |
May. 14 | Jefferies Adjusts Japan Tobacco’s Price Target to 3,741 Yen From 3,353 Yen, Keeps at Hold | MT |
May. 10 | Japan Tobacco's Attributable Profit Up 9% in Q1 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.37% | 49.71B | |
+12.64% | 77.55B | |
-8.28% | 64.54B | |
-1.96% | 7.05B | |
-16.76% | 5.46B | |
-4.50% | 2.42B | |
-6.52% | 2.27B | |
-36.61% | 1.48B | |
-2.82% | 1.21B | |
-17.82% | 1.15B |
- Stock Market
- Equities
- 2914 Stock
- News Japan Tobacco, Inc.
- Japan Tobacco Inc. Announces Executive Changes